Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Avadel Pharmaceuticals plc (AVDL) Insider Trading Activity

    Healthcare • Drug Manufacturers - Specialty & Generic • 154 employees

    Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

    Total Value

    $761,674.61

    Total Shares

    85,579

    Average Trade Value

    $76,167.46

    Most Active Insider

    Ende Eric J

    Total Activity: $235,218

    Largest Single Transaction

    $235,218

    by Ende Eric J on Jan 13, 2025

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Director
    Jan 21, 2025 5,000 $39,640 67,900 (+7.4%) Purchase
    Director
    Jan 13, 2025 30,000 $235,218 208,900 (+14.4%) Purchase
    Director
    Jan 13, 2025 10,000 $80,450 104,055 (+9.6%) Purchase
    Chief Financial Officer
    Officer
    Dec 13, 2024 2,300 $24,019 87,800 (+2.6%) Purchase
    Chief Financial Officer
    Officer
    Dec 11, 2024 5,000 $52,433 85,500 (+5.8%) Purchase
    Director
    Dec 10, 2024 10,204 $99,999 75,904 (+13.4%) Purchase
    Director
    Dec 10, 2024 10,075 $99,642 69,075 (+14.6%) Purchase
    Chief Executive Officer
    Director, Officer
    Dec 9, 2024 402 $3,948 10,000 (+4.0%) Purchase
    Director
    Dec 6, 2024 3,000 $30,568 66,400 (+4.5%) Purchase
    Chief Executive Officer
    Director, Officer
    Dec 6, 2024 9,598 $95,759 9,598 (+100.0%) Purchase